Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.28K / 1.87M |
Day Range | - - - |
52 Wk Range | 5.70 - 12.14 |
Market Cap | $1.24B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 6.81% |
Days to Cover | 12.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Prothena Corp (NASDAQ:PRTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Relay Therapeutics has a consensus price target of $24.00.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $7.66 last updated September 24, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.